The Michael J. Fox Foundation Funds DiaGenic’s Development Of First Parkinson’s Blood Test

DiaGenic ASA announced that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) is funding a DiaGenic study with Dr. Clemens R. Scherzer, Assistant Professor of Neurology at Brigham and Women’s Hospital and Harvard Medical School, to develop the first blood test for Parkinson’s disease: a gene expression signature for the early detection of PD. This involves the identification and independent validation of a unique gene expression signature for Parkinson’s using peripheral blood. [click link for full article]

More: continued here

Filed under: Parkinson's Disease on December 24th, 2007